Bronwyn M Kivell
7PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Sep 02, 2025
Role of β-Arrestin 2 in the antinociceptive and side effect profile of morphine and the novel mu opioid receptor agonists, kurkinorin and kurkinol.Ross van de Wetering, Amy F Alder, Andrew Biggerstaff
|Feb 13, 2025
Effects of Biased Analogues of the Kappa Opioid Receptor Agonist, U50,488, in Preclinical Models of Pain and Side Effects.Ross van de Wetering, Loan Y Vu, Lindsay D Kornberger
|Jun 20, 2024
Nalfurafine promotes myelination in vitro and facilitates recovery from cuprizone + rapamycin-induced demyelination in mice.Ross van de Wetering, Rabia Bibi, Andy Biggerstaff
|Jun 28, 2023
The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors.Ross van de Wetering, Amy Ewald, Susan Welsh
|Dec 23, 2022
Sex Differences in the Behavioural Aspects of the Cuprizone-Induced Demyelination Model in Mice.Kelly F Paton, Sheein Hong, Andrew Biggerstaff
|Jan 25, 2021
Nalfurafine reduces neuroinflammation and drives remyelination in models of CNS demyelinating disease.Lisa Denny, Afnan Al Abadey, Katharina Robichon
Pageof 2
